Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy

Epilepsia

Volumn 41, Issue 3, 2000, Pages 338-341

  Lhatoo, S D ^a,c   Wong, I C K ^b   Sander, J W A S ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c Epilepsy Research Group   (United Kingdom)

Author keywords

Chronic epilepsy; Prognostic factors; Retention; Topiramate

Indexed keywords

GABAPENTIN; LAMOTRIGINE; TOPIRAMATE; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG RETENTION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034008032     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00165.x     Document Type: Article

References (13)

1. Sander JWAS. New drugs for epilepsy. Curr Opin Neurol 1998; 11:141-8.
2. Reife RA, Pledger GW. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double blind, placebo controlled trials. Epilepsia 1997;38(suppl 1):S31-3.
3. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313: 1169-74.
4. Mignot G. Drug trials in epilepsy. BMJ 1996;313:1158.
5. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy: UK lamotrigine/carbamazepine monotherapy trial group. Lancet 1995; 345:476-9.
6. Kellet MW, Smith DF, Stockton PA, Chadwick DW. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry 1999;66: 759-63.
7. Wong ICK. New antiepileptic drugs: study suggests that a quarter of patients will still be taking the new drugs after six years. BMJ 1997;314:603-4.
8. Kaplan EL. Non-parametric estimation from incomplete observations. Am Stat Assoc J 1958;53:457-81.
9. Cox DR. Regression models and life tables. J R Stat Soc 1972;34: 187-202.
10. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
11. World Health Organization. Guidelines for ATC classification and DDD assignment. WHO, 1996.
12. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
13. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-7.